(Q37532654)

20 August 2017

1 reference

title

Key targets of hormonal treatment of prostate cancer. Part 1: the androgen receptor and steroidogenic pathways (English)

1 reference

20 August 2017

1 reference

André N Vis

1

1 reference

20 August 2017

Fritz H Schröder

series ordinal

2

1 reference

20 August 2017

language of work or name

1 reference

24 June 2009

1 reference

20 August 2017

1 reference

20 August 2017

volume

104

1 reference

20 August 2017

issue

4

1 reference

20 August 2017

page(s)

438-448

1 reference

Statins and cancer prevention

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2009.08695.X

STUDIES ON PROSTATIC CANCER

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2009.08695.X

Single-therapy androgen suppression in men with advanced prostate cancer: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2009.08695.X

A controlled trial of leuprolide with and without flutamide in prostatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2009.08695.X

The development of androgen-independent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2009.08695.X

Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2009.08695.X

10.1111/J.1464-410X.2009.08695.X

21 January 2018

Identifiers

DOI

1 reference

20 August 2017

1 reference